Home141080 • KOSDAQ
add
LigaChem Biosciences Inc
Previous close
₩110,900.00
Day range
₩105,000.00 - ₩111,500.00
Year range
₩58,800.00 - ₩143,600.00
Market cap
4.01T KRW
Avg Volume
325.00K
P/E ratio
483.40
Dividend yield
-
Primary exchange
KOSDAQ
Market news
MarketWatch
16 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 33.67B | 266.46% |
Operating expense | 43.07B | 42.66% |
Net income | -5.42B | 66.45% |
Net profit margin | -16.10 | 90.84% |
Earnings per share | — | — |
EBITDA | -12.41B | 48.20% |
Effective tax rate | -15.50% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 493.95B | 394.32% |
Total assets | 738.38B | 289.64% |
Total liabilities | 122.38B | 196.47% |
Total equity | 616.00B | — |
Shares outstanding | 36.28M | — |
Price to book | 6.53 | — |
Return on assets | -4.67% | — |
Return on capital | -5.41% | — |
Cash Flow
Net change in cash
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.42B | 66.45% |
Cash from operations | 14.56B | 184.63% |
Cash from investing | -11.08B | -262.43% |
Cash from financing | -29.56B | -11,741.37% |
Net change in cash | -24.73B | -133.23% |
Free cash flow | 13.59B | 184.16% |
About
CEO
Founded
2006
Website
Employees
163
